Akili Inc Asset Turnover Ratio (AKLI), as of first quarter 2024, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Akili Inc   (NASDAQ: AKLI)
 

Akili Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Akili Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.02 in the first quarter (Mar 31 2024)

Within sector 50 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2024 compared to the preceding quarter from 1579 to 1598.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AKLI Asset Turnover Ratio (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter
Y / Y Asset Change -46.11 % -44.56 % -44.43 % -56.41 % -51.28 %
Y / Y Revenue Change 238.94 % 574.77 % 756.1 % 78.13 % 71.21 %
Asset Turnover Ratio (TTM) 0.02 0.02 0.01 0 0
AKLI's Total Ranking # 1598 # 1579 # 3826 # 1110 # 0
Seq. Asset Change -16.36 % -13.77 % -16.59 % -10.42 % -13.94 %
Seq. Revenue Change -48.87 % 6.7 % 515.79 % 0.88 % 1.8 %



Asset Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 51
Healthcare Sector # 170
Overall Market # 1598

Asset Turnover Ratio Statistics
High Average Low
10.78 8.52 7.6
(Jun 30 2023)   (Sep 30 2023)




AKLI Company Profile • Back to AKLI Efficiency Comparisons • Compare AKLI Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2024 Assets at quarter ending Mar 31 2024
Caribou Biosciences Inc   0.08 $ 33.404  Millions$ 411.551  Millions
Solana Company  0.08 $ 0.668  Millions$ 8.264  Millions
Longeveron Inc   0.08 $ 0.978  Millions$ 12.623  Millions
Dbv Technologies S a   0.08 $ 14.941  Millions$ 194.704  Millions
Arch Therapeutics Inc   0.08 $ 0.131  Millions$ 1.721  Millions
Lineage Cell Therapeutics Inc   0.07 $ 8.003  Millions$ 106.836  Millions
Bicycle Therapeutics Plc  0.07 $ 41.610  Millions$ 558.835  Millions
Recursion Pharmaceuticals Inc   0.07 $ 46.235  Millions$ 627.267  Millions
Bluebird Bio Inc   0.07 $ 45.689  Millions$ 631.911  Millions
Tff Pharmaceuticals Inc  0.07 $ 0.886  Millions$ 12.417  Millions
Bolt Biotherapeutics Inc   0.07 $ 11.324  Millions$ 167.182  Millions
Co diagnostics Inc   0.07 $ 6.678  Millions$ 100.869  Millions
Soligenix inc   0.07 $ 0.699  Millions$ 10.746  Millions
Mountain Crest Acquisition Corp V  0.06 $ 0.367  Millions$ 5.672  Millions
Adaptimmune Therapeutics Plc  0.06 $ 18.358  Millions$ 295.062  Millions
Arvinas Inc   0.06 $ 71.300  Millions$ 1,164.750  Millions
Zivo Bioscience Inc   0.06 $ 0.063  Millions$ 1.046  Millions
Omniab Inc   0.06 $ 21.046  Millions$ 381.182  Millions
C4 Therapeutics Inc   0.05 $ 20.036  Millions$ 370.711  Millions
Tscan Therapeutics Inc   0.05 $ 14.812  Millions$ 280.321  Millions
Viskase Holdings inc   0.05 $ 2.461  Millions$ 47.050  Millions
60 Degrees Pharmaceuticals Inc   0.05 $ 0.342  Millions$ 6.546  Millions
Femasys Inc   0.05 $ 1.049  Millions$ 20.324  Millions
Foxo Technologies Inc   0.05 $ 0.139  Millions$ 2.724  Millions
Synlogic Inc   0.05 $ 3.205  Millions$ 64.286  Millions
Anaptysbio Inc   0.05 $ 22.962  Millions$ 465.663  Millions
4d Molecular Therapeutics Inc   0.05 $ 20.453  Millions$ 420.973  Millions
Sab Biotherapeutics Inc   0.05 $ 2.602  Millions$ 54.773  Millions
Northwest Biotherapeutics Inc  0.05 $ 1.336  Millions$ 29.091  Millions
Astrotech Corp  0.05 $ 2.004  Millions$ 43.835  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.